-
1
-
-
0031896344
-
U.S. double-blind, controlled trials of omeprazole and amoxicillin for treatment of H. pylori
-
Laine L., Johnson E., Suchower L., et al. U.S. double-blind, controlled trials of omeprazole and amoxicillin for treatment of H. pylori. Aliment Pharmacol Ther. 12:1998;377-382.
-
(1998)
Aliment Pharmacol Ther
, vol.12
, pp. 377-382
-
-
Laine, L.1
Johnson, E.2
Suchower, L.3
-
2
-
-
0030775973
-
What are the treatment goals for Helicobacter pylori infection
-
Fennerty M.B. What are the treatment goals for Helicobacter pylori infection. Gastroenterology. 113:1997;S120-S125.
-
(1997)
Gastroenterology
, vol.113
-
-
Fennerty, M.B.1
-
3
-
-
0030731496
-
What other treatment regimens are under investigation to treat Helicobacter pylori infection
-
Unge P. What other treatment regimens are under investigation to treat Helicobacter pylori infection. Gastroenterology. 113:1997;S131-S148.
-
(1997)
Gastroenterology
, vol.113
-
-
Unge, P.1
-
4
-
-
0001043167
-
How do clinicians in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians
-
Breuer T., Goodman K.J., Malaty H.M., et al. How do clinicians in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians. Am J Gastroenterol. 93:1998;553-561.
-
(1998)
Am J Gastroenterol
, vol.93
, pp. 553-561
-
-
Breuer, T.1
Goodman, K.J.2
Malaty, H.M.3
-
5
-
-
0030223132
-
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH 1 Study
-
Lind T., van Zanten S.J.O.V., Unge P., et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials the MACH 1 Study . Helicobacter. 1:1996;138-144.
-
(1996)
Helicobacter
, vol.1
, pp. 138-144
-
-
Lind, T.1
Van Zanten, S.J.O.V.2
Unge, P.3
-
6
-
-
0030611919
-
A United States multicentre trial of dual and proton pump inhibitior-based triple therapies for Helicobacter pylori
-
Laine L., Frantz J.E., Baker A., Neil G.A. A United States multicentre trial of dual and proton pump inhibitior-based triple therapies for Helicobacter pylori. Aliment Pharmacol Ther. 11:1997;913-917.
-
(1997)
Aliment Pharmacol Ther
, vol.11
, pp. 913-917
-
-
Laine, L.1
Frantz, J.E.2
Baker, A.3
Neil, G.A.4
-
7
-
-
0030016498
-
One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection
-
Yousfi M.M., El-Zimaity, Cole R.A., et al. One-week triple therapy with omeprazole, amoxycillin and clarithromycin for treatment of Helicobacter pylori infection. Aliment Pharmacol Ther. 10:1996;617.
-
(1996)
Aliment Pharmacol Ther
, vol.10
, pp. 617
-
-
Yousfi, M.M.1
El-Zimaity2
Cole, R.A.3
-
8
-
-
0030308983
-
Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection: A short report
-
Schwartz H., Krause R., Siepman N., et al. Seven-day triple therapy with lansoprazole, clarithromycin, and metronidazole for the cure of Helicobacter pylori infection a short report . Helicobacter. 1:1996;251-255.
-
(1996)
Helicobacter
, vol.1
, pp. 251-255
-
-
Schwartz, H.1
Krause, R.2
Siepman, N.3
-
9
-
-
0029820444
-
Randomized comparison of differing periods of twice-a-day therapy for the eradication of Helicobacter pylori
-
Laine L., Estrada R., Trujillo M., et al. Randomized comparison of differing periods of twice-a-day therapy for the eradication of Helicobacter pylori. Aliment Pharmacol Ther. 10:1996;1029-1033.
-
(1996)
Aliment Pharmacol Ther
, vol.10
, pp. 1029-1033
-
-
Laine, L.1
Estrada, R.2
Trujillo, M.3
-
10
-
-
0003298571
-
The MACH 2 study: Optimal Helicobacter pylori therapy need omeprazole and can be reliably assessed by UBT
-
(abstract)
-
Lind T., Bardhan K.D., Bayerdorffer E., et al. The MACH 2 study optimal Helicobacter pylori therapy need omeprazole and can be reliably assessed by UBT . Gastroenterology. 112:1997;A200. (abstract).
-
(1997)
Gastroenterology
, vol.112
, pp. 200
-
-
Lind, T.1
Bardhan, K.D.2
Bayerdorffer, E.3
-
11
-
-
0001229082
-
In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials
-
(abstract)
-
Weissfeld A.S., Simmons D.E., Vance P.H., et al. In vitro susceptibility of pre-treatment isolates of Helicobacter pylori from two multicenter United States clinical trials. Gastroenterology. 110:1996;A295. (abstract).
-
(1996)
Gastroenterology
, vol.110
, pp. 295
-
-
Weissfeld, A.S.1
Simmons, D.E.2
Vance, P.H.3
-
12
-
-
0008325246
-
One week low-dose triple therapy for eradication of H. pylori: A large multicentre, randomised trial
-
(abstract)
-
Misiewicz J.J., Harris A.W., Bardhan K.D., et al. One week low-dose triple therapy for eradication of H. pylori: a large multicentre, randomised trial. Gastroenterology. 110:1996;A198. (abstract).
-
(1996)
Gastroenterology
, vol.110
, pp. 198
-
-
Misiewicz, J.J.1
Harris, A.W.2
Bardhan, K.D.3
-
13
-
-
0030830693
-
-
The Report on the Digestive Health Initiative International Update Conference on Helicobacter pylori. Gastroenterology. 113:1997;S4-S8.
-
(1997)
Gastroenterology
, vol.113
-
-
-
14
-
-
0032563694
-
A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori
-
Fennerty M.B., Kovacs T.O.G., Krause R., et al. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. Arch Intern Med. 158:1998;1651-1656.
-
(1998)
Arch Intern Med
, vol.158
, pp. 1651-1656
-
-
Fennerty, M.B.1
Kovacs, T.O.G.2
Krause, R.3
|